References
Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW, Matisse Investigators. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med. 2004;140:867–73.
Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002;162:1833–40.
White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998;158:1525–31.
Urbankova J, Quiroz R, Kucher N, Goldhaber SZ. Intermittent pneumatic compression and deep vein thrombosis prevention. A metaanalysis in postoperative patients. Thromb Haemost. 2005;94:1181–5.
Warwick D, Harrison J, Glew D, Mitchelmore A, Peters TJ, Donovan J. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. J Bone Joint Surg. 1998;80:1158–66.
Acknowledgments
The authors thank Mr. Rhuhei Kanda and Ms. Yuka Nakamichi for their skilled technical assistance.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Asakura, Y., Tsuchiya, H., Nieda, Y. et al. Deep vein thrombosis: how long will it remain?. J Anesth 24, 490–491 (2010). https://doi.org/10.1007/s00540-010-0910-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-010-0910-9